Interview Questions for Keith Booher
1. Your talk emphasizes AI-driven workflows for identifying repurposed drugs. Can you share a specific case where your platform identified a treatment for a rare disease, and how it impacted patient outcomes?”
Interview Questions for Mike Snyder, PhD, Stanford
1. Can you describe a project or experience where you integrated data from wearables with multi-omics data? What were the main challenges you faced, and how did you address them?
We have several projects running right
Can Proteomics Transform Cancer Prevention? Learn from Dr. Stefánsson at PMWC Feb 5-7 – Healthcare Professional
Can we predict and prevent cancer before it strikes? Dr. Kári Stefánsson, founder of deCODE Genetics, is leading the way.
Breaking: New Quantum Chip cuts Eons to 5min! – Hear from Nvidia’s CEO on AI in Healthcare + FDA Commissioner on AI concerns + more at PMWC Feb 5-7
The future of medicine is here—and it’s powered by AI. Imagine a world where AI personalizes your treatment, transforms how diseases are detected, and revolutionizes drug development. At PMWC 2025, February 5-7 in the Santa Clara Convention Center, we’ll bring this vision to life, showcasing how AI is reshaping healthcare and accelerating precision medicine.
Interview Questions for Dan Chen, MD, PhD, Genesis Biocapital
1. With your extensive background at Genentech and foundational contributions to the Cancer-Immunity Cycle, can you share some insights on the key challenges and breakthroughs in cancer immunotherapy over the past decade, and how these have influenced the development of new therapies?
Cancer Fragmentation, Multi-Cancer Detection & Liquid Biopsy Innovation with Victor Velculescu & Nicola Aceto at PMWC 2025!
Dr. Victor Velculescu’s work with DELFI technology exemplifies these advancements. Using AI to analyze genome-wide cell-free DNA fragmentation, DELFI offers a breakthrough in early cancer detection. “This new machine-learning fragmentome approach provides a sensitive and accessible next-generation liquid biopsy method,” he explains, highlighting the importance of collaboration to bring these technologies into real-world clinical settings and improve patient outcomes.
NIH’s $110M Women’s Health Investment – Join PMWC 2025’s Women’s Health Track
Have you heard about the Historic $110M NIH Investment in Women’s Health? Following the NIH’s announcement of this ARPA-H funding, the PMWC 2025 Silicon Valley (Feb 5-7 Program) Women’s Health Track is primed to spotlight innovations that align with this transformative support.
The Dawn of Digital Biology: Jensen Huang’s (NVIDIA) Vision for AI in Healthcare at PMWC25
In a world where technology and healthcare converge, the visionary leadership of Jensen Huang, the CEO of NVIDIA is pioneering a revolution that could redefine our approach to medicine and biology. We are thrilled to announce that Jensen Huang will be the Luminary honoree at the PMWC 2025 Silicon Valley track on AI and Data Science in Research and Development in Track 2 on February 7th (View the full February 5-7 Silicon Valley Program).
Interview Questions for Michael E. Phelps, UCLA
Given the significant advancements in PET radiopharmaceuticals over the past decade, what do you see as the most promising areas for future development?
Interview Questions for Kari Stefansson, CEO of deCODE Genetics
Can you share details about a current project at deCODE that excites you the most, whether in multiomics or another area of research?